Investigating spillover of multidrug-resistant tuberculosis from a prison: a spatial and molecular epidemiological analysis

被引:43
|
作者
Warren, Joshua L. [1 ]
Grandjean, Louis [2 ,3 ]
Moore, David A. J. [3 ,4 ]
Lithgow, Anna [4 ]
Coronel, Jorge [3 ]
Sheen, Patricia [3 ]
Zelner, Jonathan L. [5 ]
Andrews, Jason R. [6 ]
Cohen, Ted [7 ]
机构
[1] Yale Univ, Dept Biostat, New Haven, CT 06510 USA
[2] Imperial Coll, Dept Med, Sect Paediat, Paediat Infect Dis, London W2 1NY, England
[3] Univ Peruana Cayetano Heredia, Lab Invest & Desarrollo, Lima, Peru
[4] London Sch Hyg & Trop Med, TB Ctr & Dept Clin Res, London, England
[5] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA
[6] Stanford Univ, Dept Med, Stanford, CA 94305 USA
[7] Yale Univ, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA
来源
BMC MEDICINE | 2018年 / 16卷
基金
美国国家卫生研究院; 英国惠康基金;
关键词
Antibiotic resistance; Bayesian statistics; Spatial analysis; Spillover analysis; Transmission; DRUG-RESISTANCE; MYCOBACTERIUM-TUBERCULOSIS; CROSS-VALIDATION; TRANSMISSION; EPIDEMICS; MODEL; COMMUNITY; SETTINGS; DYNAMICS; BURDEN;
D O I
10.1186/s12916-018-1111-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Congregate settings may serve as institutional amplifiers of tuberculosis (TB) and multidrug-resistant tuberculosis (MDR-TB). We analyze spatial, epidemiological, and pathogen genetic data prospectively collected from neighborhoods surrounding a prison in Lima, Peru, where inmates experience a high risk of MDR-TB, to investigate the risk of spillover into the surrounding community. Methods: Using hierarchical Bayesian statistical modeling, we address three questions regarding the MDR-TB risk: (i) Does the excess risk observed among prisoners also extend outside the prison? (ii) If so, what is the magnitude, shape, and spatial range of this spillover effect? (iii) Is there evidence of additional transmission across the region? Results: The region of spillover risk extends for 5.47 km outside of the prison (95% credible interval: 1.38, 9.63 km). Within this spillover region, we find that nine of the 467 non-inmate patients (35 with MDR-TB) have MDR-TB strains that are genetic matches to strains collected from current inmates with MDR-TB, compared to seven out of 1080 patients (89 with MDR-TB) outside the spillover region (p values: 0.022 and 0.008). We also identify eight spatially aggregated genetic clusters of MDR-TB, four within the spillover region, consistent with local transmission among individuals living close to the prison. Conclusions: We demonstrate a clear prison spillover effect in this population, which suggests that interventions in the prison may have benefits that extend to the surrounding community.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Treatment of multidrug-resistant tuberculosis
    Colebunders, R
    Apers, L
    Shamputa, IC
    LANCET, 2004, 363 (9416): : 1240 - 1240
  • [42] Transmission of multidrug-resistant tuberculosis
    Schaaf, HS
    Van Rie, A
    Gie, RP
    Beyers, N
    Victor, TC
    Van Helden, PD
    Donald, PR
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (08) : 695 - 699
  • [43] Multidrug-resistant Tuberculosis in Children
    Shah, Ira
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (09) : 970 - 972
  • [44] Preventing multidrug-resistant tuberculosis
    Bloch, AB
    Simone, PM
    McCray, E
    Castro, KG
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (06): : 487 - 489
  • [45] REINFECTION WITH MULTIDRUG-RESISTANT TUBERCULOSIS
    LIN, BTY
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (11): : 811 - 812
  • [46] CLUSTERS OF MULTIDRUG-RESISTANT TUBERCULOSIS
    EDLIN, BR
    VALWAY, SE
    ONORATO, IM
    ANNALS OF INTERNAL MEDICINE, 1993, 118 (01) : 77 - 77
  • [47] Multidrug-resistant tuberculosis - This is the cost
    Moore-Gillon, J
    NEW VISTAS IN THERAPEUTICS, FROM DRUG DESIGN TO GENE THERAPY: DRUG-RESISTANT TUBERCULOSIS, FROM MOLECULES TO MACRO-ECONOMICS, 2001, 953 : 233 - 240
  • [48] Quinolones and multidrug-resistant tuberculosis
    Maranetra, KN
    CHEMOTHERAPY, 1999, 45 : 12 - 18
  • [49] Managing multidrug-resistant tuberculosis
    Antoun, F.
    Veziris, N.
    REVUE DES MALADIES RESPIRATOIRES, 2011, 28 (08) : 956 - 957
  • [50] Fluoroquinolones in multidrug-resistant tuberculosis
    Mohapatra, PR
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (08) : 920 - 921